RF
UTHR icon

Rossby Financial’s United Therapeutics UTHR Stock Holding History

Rossby Financial’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.02M Sell
1,881
-3
-0.2% -$1.69K 0.19% 107
2026
Q1 		$1.07M Buy
1,884
+69
+4% +$34.4K 0.22% 96
2025
Q4 		$884K Buy
1,815
+85
+5% +$39.6K 0.27% 68
2025
Q3 		$758K Sell
1,730
-73
-4% -$24.6K 0.25% 78
2025
Q2 		$518K Buy
1,803
+499
+38% +$149K 0.19% 105
2025
Q1 		$380K Buy
1,304
+586
+82% +$201K 0.16% 134
2024
Q4 		$253K Buy
+718
New +$264K 0.16% 152

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Rossby Financial's UTHR Position: Q2 2026 in Review

Rossby Financial reduced its United Therapeutics (UTHR) stake by 0.16% in Q2 2026, selling an estimated $1.69K and leaving 1,881 shares worth $1.02M. The position accounts for 0.19% of the portfolio, ranked #107.

Rossby Financial first reported a position in UTHR in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.07M in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Rossby Financial held 1,881 shares of United Therapeutics worth $1.02M as of Q2 2026.
  • Rossby Financial sold 3 United Therapeutics shares in Q2 2026, an estimated $1.69K.
  • United Therapeutics made up 0.19% of Rossby Financial's portfolio in Q2 2026, its #107 holding.
  • Rossby Financial first reported a position in United Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Rossby Financial's United Therapeutics position peaked at $1.07M in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Rossby Financial's 13F filing for Q2 2026, filed 4 Aug 2026.